1. Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma. (4th August 2022) Authors: Koczka, Kim; Rigo, Rodrigo; Batuyong, Eugene; Cook, Sara; Asad, Mohammad; Vallerand, Isabelle; Suo, Aleksi; Wang, Edwin; Cheng, Tina Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 2427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study. Issue 4 (5th September 2022) Authors: Jimenez‐Zepeda, Victor H.; Reece, Donna; Rigo, Rodrigo; Gogna, Priyanka; Kong, Shiying; Hu, Xun Yang; Chapani, Parv; Cheung, Winson Y.; Brenner, Darren R.; Plante, Richard; Shi, Kun; Husain, Asad; Tankala, Dipti; Boyne, Devon J. Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data. Issue 1 (2nd January 2023) Authors: Jimenez-Zepeda, Victor H.; Reece, Donna; Rigo, Rodrigo; Gogna, Priyanka; Kong, Shiying; Hu, Xun Yang; Chapani, Parv; Cheung, Winson Y.; Brenner, Darren R.; Plante, Richard; Shi, Kun; Husain, Asad; Ammann, Eric; Tankala, Dipti; Boyne, Devon J. Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗